Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: W
Results 1 - 10 of 49 shown below

  • Waf-1

    A S Y W Burns, E Jaros, M Cole, R Perry, A J Pearson and J Lunec

    The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system

    doi:10.1038/sj.bjc.6600151

  • WAF1

    M Rusin, D Butkiewicz, E Malusecka, A Zborek, J Harasim, K Czyzewski, W P Bennett, P G Shields, A Weston, J A Welsh, S Krzyzowska-Gruca, M Chorazy and C C Harris

    Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland

    doi:10.1038/sj.bjc.6690542

  • waiting time

    S Y El Sharouni, H B Kal and J J Battermann

    Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy

    doi:10.1038/sj.bjc.6601418

  • waiting times

    P P Melling, A C Hatfield, M F Muers, M D Peake, C J Storer, C E Round, R A Haward and S M Crawford

    Lung cancer referral patterns in the former Yorkshire region of the UK

    doi:10.1038/sj.bjc.6600029

  • D Robinson, C M J Bell, H Møller and I Basnett

    Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England

    doi:10.1038/sj.bjc.6601149

  • M Birchall, D Bailey and P King

    Effect of process standards on survival of patients with head and neck cancer in the south and west of England

    advance online publication, 2004-10-05 00:00:00.000;

    doi:10.1038/sj.bjc.6602118

  • D Robinson, T Massey, E Davies, R H Jack, A Sehgal and H Møller

    Waiting times for radiotherapy: variation over time and between cancer networks in southeast England

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602463

  • N R Lewis, I Le Jeune and D R Baldwin

    Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway

    advance online publication, 2005-09-27 00:00:00.000;

    doi:10.1038/sj.bjc.6602798

  • N Saint-Jacques, T Younis, R Dewar and D Rayson

    Wait times for breast cancer care

    advance online publication, 2006-12-19 00:00:00.000;

    doi:10.1038/sj.bjc.6603523

  • M V Williams, K J Drinkwater, A Jones, B O'Sullivan and D Tait

    Waiting times for systemic cancer therapy in the United Kingdom in 2006

    doi:10.1038/sj.bjc.6604529

  • Waldeyer's ring

    S Regauer, S Mannweiler, W Anderhuber, A Gotschuli, A Berghold, J Schachenreiter, R Jakse and A Beham

    Cystic lymph node metastases of squamous cell carcinoma of Waldeyer's ring origin

    doi:10.1038/sj.bjc.6690229

  • warts

    S M Montgomery, A G C Ehlin, P Sparén, B Björkstén and A Ekbom

    Childhood indicators of susceptibility to subsequent cervical cancer

    doi:10.1038/sj.bjc.6600585

  • E Perea-Milla López, R M Miñarro-del Moral, C Martínez-García, R Zanetti, S Rosso, S Serrano, J F Aneiros, A Jimenez-Puente and M Redondo

    Lifestyles, environmental and phenotypic factors associated with lip cancer: a case–control study in southern Spain

    doi:10.1038/sj.bjc.6600975

  • R Talamini, S Vaccarella, F Barbone, A Tavani, C La Vecchia, R Herrero, N Muñoz and S Franceschi

    Oral hygiene, dentition, sexual habits and risk of oral cancer

    doi:10.1054/bjoc.2000.1398

  • website

    S Forbes, J Clements, E Dawson, S Bamford, T Webb, A Dogan, A Flanagan, J Teague, R Wooster, P A Futreal and M R Stratton

    COSMIC 2005

    advance online publication, 2006-01-17 00:00:00.000;

    doi:10.1038/sj.bjc.6602928

  • wedge resection

    H Nakamura, N Kawasaki, M Taguchi and K Kabasawa

    Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602414

  • weekly

    F Graziano, D Santini, E Testa, V Catalano, G D Beretta, S Mosconi, G Tonini, V Lai, R Labianca and S Cascinu

    A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer

    doi:10.1038/sj.bjc.6601280

  • R Sharma, J Graham, H Mitchell, A Brooks, S Blagden and H Gabra

    Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer

    advance online publication, 2009-02-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604914

  • weekly chemotherapy

    I Sekine, Y Nishiwaki, R Kakinuma, K Kubota, F Hojo, T Matsumoto, H Ohmatsu, K Goto, T Kodama, K Eguchi, T Shinkai, T Tamura, Y Ohe, H Kunitoh, K Yoshimura and N Saijo

    Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507

    doi:10.1038/sj.bjc.6600800

  • G Frasci, G Nicolella, P Comella, I Carreca, G DeCataldis, D Muci, C Brunetti, M Natale, F Piantedosi, A Russo, S Palmeri, G Comella and N Panza

    A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

    doi:10.1054/bjoc.2001.1741